Next Generation Sequencing (NGS) has fundamentally altered genomic research by promising ultra-fast and accurate molecular typing and diagnostics. In addition, the rapid development of this technology is intended to enhance performance and bring down DNA sequencing costs, thus widening the spectrum of possible applications including the medical diagnosis of pathogens. In this context, the EU research project PathoNGen-Trace was launched bringing together an international consortium of leading experts in the field of clinical microbiology and well known enterprises in this area.
The goal of the project is the transition of NGS from a basic research tool to a highly efficient technology for pathogen typing and diagnostics at EU level. This objective will be achieved by establishing a unique European consortium that brings together three small and medium-sized enterprises leading in the fields of “data to knowledge” and “NGS genome research” with foremost experts in the clinical microbiology of three model pathogens of high European and worldwide importance (methicillin-resistant Staphylococcus aureus, Campylobacter spp., and M. tuberculosis complex).